Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.
about
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapyMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerMiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cellsAdenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.Nuclear microRNAs in normal hemopoiesis and cancermiR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.miRNA nanotherapeutics for cancer.Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.MYC Modulation around the CDK2/p27/SKP2 AxisEffect of etoposide-induced alteration of the Mdm2-Rb signaling pathway on cellular senescence in A549 lung adenocarcinoma cells.Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer
P2860
Q26769604-4995DD62-92C8-4976-925C-5552DAB64DFCQ26801108-1F86E94F-7CDD-45D1-BC65-3BD020BB1E5EQ35759291-E51AAA03-1710-444C-A037-A04B90F2C328Q36265840-2AFF13E0-B7D4-402E-BDF0-0A59A8E48683Q36277823-62067897-5BC5-48B4-94B9-6620A4CCBB5EQ37565996-BDCCCE78-ABAB-4B75-B5AD-A8D9348C0B86Q37588157-303B9525-A586-4AB5-957E-F6DFF422A49FQ37697914-2D4AAEB5-D424-4165-A7C8-BBC65048B17CQ38999082-5010BD1E-36B6-4BFB-AF9B-6C6EA268ABADQ39391417-6209AF03-F0FC-42C9-8B10-570F74EF8C18Q39406924-5E22D656-82F4-4362-A2E4-1241669AFB8FQ41676857-6FFC7229-3C72-4054-8C6E-EFD46E2C1489Q46013493-23A716C4-DAD0-4FC0-9ED6-08C318036ABFQ47677607-A01E94C6-EB28-4F8D-90B2-B6C0EFB86CEAQ52374596-9E60398A-E4B0-4212-A602-2F4927A3E554Q58699575-12E02137-2B1F-465A-9A97-7E997DB44F42
P2860
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Functional proteomics identifi ...... in breast and ovarian cancer.
@ast
Functional proteomics identifi ...... in breast and ovarian cancer.
@en
type
label
Functional proteomics identifi ...... in breast and ovarian cancer.
@ast
Functional proteomics identifi ...... in breast and ovarian cancer.
@en
prefLabel
Functional proteomics identifi ...... in breast and ovarian cancer.
@ast
Functional proteomics identifi ...... in breast and ovarian cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Functional proteomics identifi ...... e in breast and ovarian cancer
@en
P2093
G Lopez-Berestein
R Roopaimoole
P2860
P2888
P304
P356
10.1038/ONC.2014.469
P407
P577
2015-02-02T00:00:00Z